Plasma levels of tissue inhibitor of metalloproteinases 1 (TIMP-1) and tumor type M2 pyruvate kinase (TuM2-PK) for monitoring of advanced colorectal cancer

被引：0
|
作者：
Schildhauer, S.
Pollmann, D.
Geppert, R.
Ocran, K.
Wernecke, K.-D.
Possinger, K.
Lueftner, D.
机构：
[1] Charite Univ Med Berlin, Med Klin I Onkol, Berlin, Germany
[2] Charite Univ Med Berlin, Med Klin I Gastroenterol, Berlin, Germany
[3] Charite Univ Med Berlin, Inst Med Biometry, Berlin, Germany
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [1] Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma
    Ugurel, S
    Bell, N
    Sucker, A
    Zimpfer, A
    Rittgen, W
    Schadendorf, D
    INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (05) : 825 - 830
  • [2] PREOPERATIVE TUMOR M2 PYRUVATE KINASE (TuM2-PK) AS A PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA (RCC)
    Nisman, B.
    Nechushtan, H.
    Yutkin, V.
    Peretz, T.
    Gofrit, O.
    Pode, D.
    TUMOR BIOLOGY, 2010, 31 : S115 - S116
  • [3] Tissue inhibitor of metalloproteinases-1 (TIMP-1) as tumor marker in colorectal cancer
    Nanna, Sorensen M.
    Blincko, S.
    Weerakoon, A.
    Dinsmore, E. J.
    Lally, J. P.
    Rogers, B. C.
    Christensen, I. J.
    Jensen, V
    Bruenner, N.
    Nielsen, H. J.
    Dowel, B.
    Davis, G.
    TUMOR BIOLOGY, 2006, 27 : 38 - 38
  • [4] Serum levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) in colorectal cancer patients
    Ishida, H
    Murata, N
    Hayashi, Y
    Tada, M
    Hashimoto, D
    SURGERY TODAY, 2003, 33 (12) : 885 - 892
  • [5] Serum Levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) in Colorectal Cancer Patients
    Hideyuki Ishida
    Nobuo Murata
    Yoichi Hayashi
    Masakazu Tada
    Daijo Hashimoto
    Surgery Today, 2003, 33 : 885 - 892
  • [6] Tissue inhibitor of metalloproteinases 1 (TIMP-1) as an immunohistochemical marker for colorectal cancer
    Sorensen, I.
    Winther, H.
    Foged, N.
    Fenger, C.
    Brunner, N.
    EJC SUPPLEMENTS, 2005, 3 (02): : 196 - 196
  • [7] TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions
    Cerwenka, H
    Aigner, R
    Bacher, H
    Werkgartner, G
    El-Shabrawi, A
    Quehenberger, F
    Mischinger, HJ
    ANTICANCER RESEARCH, 1999, 19 (1B) : 849 - 851
  • [8] Tumor type M2 pyruvate kinase expression in advanced breast cancer
    Lüftner, D
    Mesterharm, J
    Akrivakis, C
    Geppert, R
    Petrides, PE
    Wernecke, KD
    Possinger, K
    ANTICANCER RESEARCH, 2000, 20 (6D) : 5077 - 5082
  • [9] Pyruvate kinase M2 (tumor M2-PK) as a screening tool for colorectal cancer (CRC). A review
    Ewald, N
    Toepler, M
    Akinci, A
    Kloer, HU
    Bretzel, RG
    Hardt, PD
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2005, 43 (12): : 1313 - 1317
  • [10] Independent prognostic value of plasma tissue inhibitor of metalloproteinases-1 (TIMP-1) in colorectal cancer: A prospective validation study
    Nielsen, H. J.
    Ghanipour, A.
    Christensen, I. J.
    Glimelius, B.
    Brunner, N.
    Birgisson, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345